3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Other solid neoplasm
1
Genitourinary
1
Gastrointestinal
1
CNS
1
Conditions
Wilms Tumor
1
Stomach Neoplasms
1
Sarcoma, Ewing
1
Sarcoma, Clear Cell
1
Sarcoma
1
Rhabdomyosarcoma
1
Rhabdoid Tumor
1
Retinoblastoma
1
Osteosarcoma
1
Neuroblastoma
1
Neoplasms, Germ Cell and Embryonal
1
Neoplasms
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Hepatoblastoma
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Advanced Pancreatic Cancer
1
Interventions
Cyclophosphamide
9
Topotecan
5
Temozolomide
5
Melphalan
5
Irinotecan
5
Busulfan
5
fludarabine
4
Granulocyte Colony-Stimulating Factor
4
Filgrastim
4
liposomal doxorubicin
3
fludarabine phosphate
3
cabozantinib
3
Vincristine
3
regorafenib
2
pegfilgrastim
2
Sirolimus
2
Doxorubicin
2
Bone Marrow Transplantation
2
trioctyl phosphine oxide
1
trifluridine tipiracil drug combination
1
thymoglobulin
1
talazoparib
1
selinexor
1
seclidemstat
1
racotumomab
1
poly ICLC
1
pembrolizumab
1
pegylated granulocyte colony-stimulating factor
1
olaparib
1
niraparib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Sarcoma, Ewing
×
Simvastatin
×
Clear all
NCT02390843
2020-04-03
AflacST1402
Emory University
Phase 1
Completed
13 enrolled